The role of MIF in chronic lung diseases: Looking beyond inflammationFlorez-Sampedro, L., Soto-Gamez, A., Poelarends, G. J. & Melgert, B. N., Jun-2020, In : American Journal of Physiology - Lung Cellular and Molecular Physiology. 318, 6, p. L1183-L1197
Research output: Contribution to journal › Article › Academic › peer-review
Macrophage migration inhibitory factor (MIF) is a pleiotropic cytokine that has been associated with many diseases. Most studies found in literature describe MIF as a proinflammatory cytokine involved in chronic inflammatory conditions, but evidence from last years suggests that many of its key effects are not directly related to inflammation. In fact, MIF is constitutively expressed in most human tissues and in some cases in high levels, which does not reflect the pattern of expression of a classic proinflammatory cytokine. Moreover, MIF is highly expressed during embryonic development and decreases during adulthood, which point towards a more likely role as growth factor. Accordingly, MIF knockout mice develop age-related spontaneous emphysema, suggesting that MIF presence (e.g. in younger individuals and wild-type animals) is part of a healthy lung. In view of this new line of evidence, we aimed to review data on the role of MIF in the pathogenesis of chronic lung diseases.
|Journal||American Journal of Physiology - Lung Cellular and Molecular Physiology|
|Early online date||25-Mar-2020|
|Publication status||Published - Jun-2020|